Illumina is not banned from operating in the country and will continue to serve its existing customers, a company ...

Illumina’s NGS sequencers are used to sequence DNA or RNA samples and use a technology known as sequencing by synthesis (SBS) ...

China’s Ministry of Commerce announcement does not mention Illumina’s reagents used in DNA sequencing, the analysts said in a Tuesday note, but the ban on sequencing machines alone could ...

Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...

China imposed an import ban on Illumina’s gene sequencers in response to President Trump’s escalating tariffs and trade war ...

Illumina has been barred from exporting its DNA sequencers to China, which closed its doors to the company in response to the Trump administration expanding its tariffs on the country. Previously ...

China accounts for about 7% of Illumina's sales. China's commerce ministry said in a statement that Illumina "violated the principle of normal market transactions, suspended normal transactions with ...

China banned the import of Illumina Inc. gene-sequencing machines as part of a wave of retaliatory trade measures in response to the US doubling tariffs on all Chinese goods.

Illumina is a global leader in producing the technology and machines used to analyze DNA and RNA ... bar Illumina from importing its gene sequencing machines, the company said “today’s ...

Kokoris came up with the idea of solving some of the noise issue of nanopore sequencing by converting DNA into larger surrogate polymers, and he cofounded sequencing company Stratos Genomics back in ...

Element Biosciences’ bid to claim a slice of a DNA sequencing technology market dominated by Illumina has been helped by an impressive $277 million financing round backed by a wide range of ...

China banned the import of Illumina Inc. gene-sequencing machines as part of a wave of retaliatory measures against fresh US tariffs on all Chinese goods, deepening the US company’s woes in one ...